Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TransMedics Group, Inc. develops and commercializes advanced organ preservation and transportation systems, primarily through its FDA-approved Organ Care System (OCS) platform for heart, lung, and liver transplants. The company offers innovative solutions for organ optimization, assessment, and logistics, increasing transplant access and improving outcomes. Its business model relies on device sales, disposable sets, and comprehensive logistics services, serving transplant centers worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.